Skip to main content

Table 3 Individual indicator and composite measures of patient care for selected clinical conditions by general practice for the period 01/04/2010-31/03/2011

From: Combining QOF data with the care bundle approach may provide a more meaningful measure of quality in general practice

Clinical conditions & Indicators

Payment

 

Participating general practices – codes A-I

Total

Points*

Threshold

A

B

C

D

E

F

G

H

I

All patients = n

 

Min-Max

7613

2277

2893

4567

12850

10939

3507

4600

7702

56948

CKD n(%)

  

246 (3.2)

111 (4.9)

86 (3.0)

151 (3.3)

321 (2.5)

535 (4.9)

97 (2.8)

172 (3.7)

194 (2.5)

1913 (3.4)

CKD3

11

40-70%

186 (75.2)

72 (64.9)

64 (74.4)

116 (76.8)

255 (79.4)

421 (78.7)

85 (87.6)

85 (87.6)

143 (73.7)

1472 (76.9)

CKD5

9

40-80%

245 (99.6)

110 (99.1)

86 (100)

151 (100)

316 (98.4)

532 (99.4)

96 (99.0)

96 (99.0)

192 (99.0)

1890 (98.8)

CKD6

6

40-80%

211 (85.8)

111 (100)

85 (98.8)

136 (90.1)

282 (87.9)

469 (87.7)

90 (92.8)

90 (92.8)

171 (88.1)

1707 (89.2)

Overall

  

158 (64.2)

71 (64.0)

64 (74.4)

105 (69.5)

225 (70.1)

380 (71.0)

79 (81.4)

79 (81.4)

129 (66.5)

1320 (69.0)

STROKE/TIA n(%)

  

173 (2.3)

62 (2.7)

75 (2.6)

100 (2.2)

309 (2.4)

248 (2.3)

67 (1.9)

112 (2.4)

129 (1.7)

1275 (2.2)

STR6

5

40-70%

165 (95.4)

52 (83.9)

67 (89.3)

90 (90.0)

288 (93.2)

226 (91.1)

56 (83.6)

105 (93.8)

118 (91.5)

1167 (91.5)

STR8

5

40-60%

158 (91.3)

48 (77.4)

60 (80.0)

81 (81.0)

283 (91.6)

213 (85.9)

58 (86.6)

95 (84.8)

110 (85.3)

1106 (86.7)

STR12

4

40-90%

166 (96.0)

60 (96.8)

72 (96.0)

96 (96.0)

305 (98.7)

235 (94.8)

65 (97.0)

108 (96.4)

125 (96.9)

1232 (96.6)

STR10

2

40-85%

151 (87.3)

59 (95.2)

73 (97.3)

96 (96.0)

293 (94.8)

234 (94.4)

61 (91.0)

104 (92.9)

124 (96.1)

1195 (93.7)

Overall

  

129 (74.6)

32 (51.6)

52 (69.3)

66 (66.6)

256 (82.8)

179 (72.2)

43 (64.2)

84 (75.0)

96 (74.4)

945 (74.1)

Diabetes Mellitus n(%)

 

275 (3.6)

120 (5.3)

159 (5.5)

156 (3.4)

520 (4.0)

458 (4.2)

163 (4.6)

181 (3.9)

366 (4.8)

2398 (4.2)

DM2

3

40-90%

265 (96.4)

120 (100)

159 (100)

151 (96.8)

506 (97.3)

449 (98.0)

159 (97.5)

175 (96.7)

356 (97.3)

2340 (97.6)

DM24

8

40-70%

250 (90.9)

95 (79.2)

140 (88.1)

133 (85.3)

432 (83.1)

359 (78.4)

136 (83.4)

148 (81.8)

296 (80.9)

1989 (82.9)

DM9

3

40-90%

244 (88.7)

119 (99.2)

147 (92.5)

151 (96.8)

475 (91.3)

421 (91.9)

159 (97.5)

165 (91.2)

353 (96.4)

2234 (93.2)

DM10

3

40-90%

244 (88.7)

119 (99.2)

147 (92.5)

150 (96.2)

475 (91.3)

422 (92.1)

159 (97.5)

166 (91.7)

351 (95.9)

2233 (93.1)

DM12

18

40-60%

244 (88.7)

105 (87.5)

144 (90.6)

118 (75.6)

459 (88.3)

375 (81.9)

133 (81.6)

166 (91.7)

329 (89.9)

2060 (85.9)

DM13

3

40-90%

253 (92.0)

119 (99.2)

154 (96.9)

140 (89.7)

484 (93.1)

426 (93.0)

149 (91.4)

153 (84.5)

345 (94.3)

2244 (93.6)

DM22

3

40-90%

269 (97.8)

120 (100.)

157 (98.7)

151 (96.8)

506 (97.3)

442 (96.5)

160 (98.2)

174 (96.1)

361 (98.6)

2346 (97.8)

DM15

3

40-80%

267 (97.1)

116 (96.7)

156 (98.1)

156 (100)

515 (99.0)

458 (100)

160 (98.2)

180 (99.4)

359 (98.1)

2363 (98.5)

DM17

6

40-70%

253 (92.0)

109 (90.8)

145 (91.2)

147 (94.2)

475 (91.3)

396 (86.5)

139 (85.3)

155 (85.6)

313 (85.5)

2132 (88.9)

DM18

3

40-85%

246 (89.5)

118 (98.3)

153 (96.2)

139 (89.1)

492 (94.6)

419 (91.5)

147 (90.2)

162 (89.5)

351 (95.9)

2227 (92.9)

Overall

  

166 (60.4)

75 (62.5)

103 ( 64.8)

84 (53.8)

339 (65.2)

239 (52.2)

82 (50.3)

100 (55.2)

213 (58.2)

1401 (58.4)

Sec prev. of CHD n(%)

 

317 (4.2)

128 (5.6)

178 (6.2)

204 (4.5)

547 (4.3)

546 (5.0)

189 (5.4)

203(4.4)

327 (4.2)

2639 (4.6)

CHD6

17

40-70%

300 (94.6)

118 (92.2)

162 (91.0)

174 (85.3)

524 (95.8)

495 (90.7)

166 (87.8)

187 (92.1)

312 (95.4)

2438 (92.4)

CHD8

17

40-70%

294 (92.7)

103 (80.5)

134 (75.3)

186 (91.2)

510 (93.2)

464 (85.0)

155 (82.0)

162 (79.8)

308 (94.2)

2316 (87.8)

CHD9

7

40-90%

293 (92.4)

120 (93.8)

172 (96.6)

199 (97.5)

541 (98.9)

511 (93.6)

172 (91.0)

195 (96.1)

319 (97.6)

2522 (95.6)

CHD10

7

40-60%

295 (93.1)

91 (71.1)

125 (70.2)

184 (90.2)

504 (92.1)

402 (73.6)

131 (69.3)

149 (73.4)

300 (91.7)

2181 (82.6)

CHD11

7

40-80%

312 (98.4)

128 (100)

178 (100)

202 (99.0)

540 (98.7)

539 (98.7)

187 (98.9)

202 (99.5)

325 (99.4)

2613 (99.0)

CHD12

7

40-90%

293 (92.4)

122 (95.3)

172 (96.6)

193 (94.6)

526 (96.2)

524 (96.0)

178 (94.2)

186 (91.6)

313 (95.7)

2507 (95.0)

Overall

  

228 (71.9)

62 (48.4)

85 (47.8)

118 (57.8)

348 (63.6)

354 (64.8)

86 (45.5)

71 (35.0)

211 (64.5)

1690 (64.0)

COPD n(%)

  

163 (2.1)

72 (3.2)

92 (3.2)

36 (0.8)

286 (2.2)

298 (2.7)

55 (1.6)

176 (3.8)

142 (1.8)

1320 (2.3)

COPD10

7

40-70%

152 (93.3)

69 (95.8)

85 (92.4)

32 (88.9)

254 (88.8)

273 (91.6)

52 (94.5)

167 (94.9)

74 (52.1)

1158 (87.7)

COPD13

9

50-90%

155 (95.1)

69 (95.8)

85 (92.4)

34 (94.4)

270 (94.4)

280 (94.0)

54 (98.2)

170 (96.6)

137 (96.5)

1254 (95.0)

COPD8

6

40-85%

150 (92.0)

72 (100)

88 (95.7)

35 (97.2)

270 (94.4)

278 (93.3)

53 (96.4)

166 (94.3)

134 (94.4)

1246 (94.4)

Overall

  

140 (85.9)

69 (95.8)

83 (90.2)

30 (83.3)

231 (80.8)

254 (85.2)

50 (90.9)

157 (89.2)

68 (47.9)

1082 (82.0)

  1. *The number of points per indicator reflects the allocated number available during the study period.